HOST-EXAM trial with CKD and DM patients
HOST-EXAM trial with CKD and DM patients
Created using ChatSlide
Join us for an insightful presentation on the HOST-EXAM Study, where we delve into the trial's design and its focus on chronic kidney disease (CKD) and diabetes mellitus (DM) patients. We compare the efficacy and safety of Clopidogrel versus Aspirin, highlighting a 24-month outcome analysis. Discover the benefits of Clopidogrel for DM patients, including the reduction of thrombotic events and improved cardiovascular health. Gain insights from Bayesian analysis regarding risk probabilities....